EDUCATIONAL NEEDS
Sickle cell disease (SCD) affects millions of people throughout the world and is particularly common among those whose ancestors came from sub-Saharan Africa; Spanish-speaking regions in the Western Hemisphere (South America, the Caribbean, and Central America); Saudi Arabia; India; and Mediterranean countries such as Turkey, Greece, and Italy. It is estimated that: SCD affects approximately 100,000 Americans. People with SCD have less access to comprehensive team care than people with other genetic disorders. Clinical research continues to explore ways to address unmet needs in managing SCD. New therapies are being researched that will focus on treating SCD at the genetic level.
As a part of the biennial renewal, consultant pharmacists are required to complete 24 hours of continuing education, which may be in 3-hour blocks. The three-hour activity may be applied towards the twenty-four-hour continuing education requirement for pharmacists. (64B16-26.103)
EDUCATIONAL OBJECTIVES
At the completion of this activity, pharmacists will be able to: Define sickle cell disease (SCD); List various types of sickle cell; Describe clinical signs associated with SCD; Outline complications of SCD; Counsel patients on lifestyle modifications and preventive strategies; Identify therapeutic agents used to manage SCD.
No Comments